共 89 条
[1]
Ackerman MJ(2011)HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) Europace 13 1077-1109
[2]
Priori SG(2008)Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics J Cardiovasc Electrophysiol 19 104-110
[3]
Willems S(2002)Phenotypic diversity in hypertrophic cardiomyopathy Hum Mol Genet 11 2499-2506
[4]
Alcalai R(2014)2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J 35 2733-2779
[5]
Seidman JG(2003)Familial hypertrophic cardiomyopathy: the same mutation, different prognosis. Comparison of two families with a long follow-up Rev Port Cardiol 22 1445-1461
[6]
Seidman CE(2010)Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 31 2715-2726
[7]
Arad M(1998)Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene Circulation 97 2230-2236
[8]
Seidman JG(1998)Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes Eur Heart J 19 139-145
[9]
Seidman CE(2019)Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians Heart 105 1892-1897
[10]
Authors TF(1995)Hypertrophic cardiomyopathy–pathology and pathogenesis Histopathology 26 493-500